U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Search Results

Sodium Chloride 23.4% Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric

Expand all

Fresenius Kabi USA, LLC (Revised 07/01/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30 mL vials (NDC 63323-0093-30) Backordered. Next release July 2022. Demand increase for the drug
100 mL vials (NDC 63323-0095-61) Backordered. Next release August 2022. Demand increase for the drug
200 mL vials (NDC 63323-0088-63) Backordered. Next release August 2022. Demand increase for the drug

Hospira, Inc. (Revised 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
400 mEq/100 mL (4 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-1141-02) Next Delivery: July 2022; Estimated Recovery: March 2023 Demand increase for the drug
Back to Top